Beam Therapeutics Inc. (BEAM) Operating income 2019–2025
Beam Therapeutics Inc. (BEAM) annual operating income history from SEC filings — each fiscal year as reported.
-$383.7MFY2025 · since FY2019: -$75.2M → -$383.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$383.7M | +7.7% |
| FY2024 | -$415.6M | -135.5% |
| FY2023 | -$176.5M | +47.9% |
| FY2022 | -$338.5M | +13.8% |
| FY2021 | -$392.5M | -195.6% |
| FY2020 | -$132.8M | -76.7% |
| FY2019 | -$75.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice